• Opko Health subsidiary GeneDx CEO Katherine Stueland named a 2026 Fierce 50 honoree for Health Equity.
• Award highlights GeneDx’s push to make earlier rare-disease diagnosis a standard part of clinical care.
• GeneDx cited its Infinity genomic dataset as a core asset supporting broader use of genomic medicine at scale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opko Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609010655BIZWIRE_USPR_____20260901_BW577181) on September 01, 2026, and is solely responsible for the information contained therein.